TP53 and neoplasm: The intrinsic apoptotic pathway, governed by the Bcl-2 family and the tumor suppressor p53, is frequently disrupted by TP53 mutations, allowing tumor cells to evade cell death and further promoting resistance to therapy (Muller and Vousden 2013; Thumpati et al. 2025).